AGP Picks
View all

Airline Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Airline Press Releases.

Press releases published on March 27, 2026

Zoomex Launches Earning Initiative as Inflation Drives Shift Toward Capital Efficiency in Crypto Markets
TMC Announces Fourth Quarter and Full Year 2025 Results
Luckin Coffee Files 2025 Annual Report on Form 20-F
Canada’s Eleventh Costco Business Centre is now open in Winnipeg
Hydrofarm Holdings Group Announces Fourth Quarter and Full Year 2025 Results
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
Communiqué de presse : La formulation sous-cutanée de Sarclisa de Sanofi, administrée via un injecteur portable, est recommandée par le CHMP pour approbation dans l'UE dans le traitement du myélome multiple
OXB recognised as ‘Most Innovative CDMO (Cell & Gene)’ at 2026 CDMO Leadership Awards
BTCS Reports 305% Year-Over-Year Revenue Growth to Record $16.5 Million for Full Year 2025
IP Strategy Highlights GenoBank’s Expansion of Onchain Genomic Data on Story
Vor Bio Announces $75 Million Private Placement with TCGX
VisionWave Announces Completion of Internal Research Paper on Conceptual RF-Based Subsurface Sensing Architectures in Connection with Recent Liberia LOE Engagement
ARMLOGI HOLDING CORP. EXPANDS INTERNAL MIDDLE-MILE TRANSPORTATION NETWORK ACROSS E-COMMERCE FULFILLMENT OPERATIONS
NN Announces Acquisition to Further Growth in Electric Grid and Data Center
Next Technology Holding Inc. Announces Closing of $157 Million Registered Direct Offering
ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label
Kyivstar Delivered 4G Coverage to 630 Communities in 2025
Aurora Mobile Limited Files Its Annual Report on Form 20-F
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies

Share this page:

Sign up for:

Airline Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.